Filing Details
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 26, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ABOS
Acumen Pharmaceuticals, Inc. (ABOS) Files Quarterly Report for Q0
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 26, 2026.
At publication ·
What changed
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Acumen Pharmaceuticals filed its quarterly 10-Q report with the SEC on October 26, 2026.
- The company's stock trades at $2.27 with a market capitalization of $190.2 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Acumen Pharmaceuticals, Inc.'s stock currently trades at $2.27 with a market capitalization of $190.2M.
The 10-Q provides Acumen Pharmaceuticals, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Acumen Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ABOS Stock Page
Frequently Asked Questions
Where can I read ABOS's SEC filings?
Browse all filings on our ABOS SEC filings page.
What types of SEC filings does Acumen Pharmaceuticals, Inc. file?
Public companies like Acumen Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.